Publikasi

The Physicians Foundation Opens Nominations for the Dr....

National award recognizes physicians confronting the drivers of health that make...

Evolutionarily Diverse Organisms Switch Genes on Simply...

A new study has found that the signals cells use to switch genes on have remaine...

New Research Greenlights Popular Obesity Medications fo...

Popular diabetes and weight-loss medications known as GLP-1 receptor agonists do...

Following court decision, Arkansas will not enforce Act...

On Tuesday July 28, the Arkansas State Board of Pharmacy suspended enforcement o...

BIO 2026: How biotechs break the $100M barrier in fundi...

The tap is opening up for venture capital in the biotech industry. Venture inves...

Receptor.AI and Sethera Plan to Create Closed-Loop Disc...

The collaboration is specifically focused on applying Receptor.AI's computationa...

Derm Deep Dive: The Best Products and Treatments for Ha...

How to Get the Most from a Hair Regrowth Plan  When you’re dealing with hair los...

Dentists’ taxable income rises across UK, with Scotland...

Self-employed dentists with some NHS or health service work saw taxable income r...

Ratio Therapeutics secures $70m Series C funding for ca...

The company said existing investors Duquesne Family Office and Bristol Myers Squ...

IMPACT Therapeutics grants Pharmanovia exclusive $488m ...

The agreement covers the use of senaparib as a maintenance monotherapy for adult...

Eisai launches LEQEMBI in India for early Alzheimer’s d...

Launch follows CDSCO marketing authorisation for disease-modifying therapy ind...

Encube Ethicals files DRHP with SEBI for Rs 3,000 crore...

IPO comprises an offer for sale by promoters and investor selling shareholder t...

Inside mydentist’s two-million-pound investment in West...

A new two-million-pound dental practice in Weston-super-Mare has brought two est...

The future of dentistry – why adaptability matters more...

Nigel Jones contrasts decades of stagnant NHS contract debates with the tech-dri...

Traceability pays back in many ways

S Swaminathan, CEO, GS1 India explains to Express Pharma the broader benefits o...

StockWatch: Capricor Plunges as FDA Panel, Staff Questi...

After seeing its lead candidate rejected by the FDA last year, Capricor Therapeu...